BusinessEndonovo Therapeutics Provides Update on Acquisition of PEMF Assets, Clinical Pipeline and Pre-Clinical StudyBy Nasdaq OMXDec 28, 2017, 2:30 PM UTC
BusinessEndonovo Therapeutics Acquires Assets of Electroceuticals Developer, Rio Grande Neurosciences, and Settles LawsuitBy Nasdaq OMXDec 26, 2017, 12:30 PM UTC